State MA
Clinical Trials in Massachusetts
Recruiting clinical trials with at least one study location in Massachusetts. Data updated daily from ClinicalTrials.gov.
Top Conditions in Massachusetts
Frequently Asked Questions — Clinical Trials in Massachusetts
How many clinical trials are currently recruiting in Massachusetts?
ClinicalMetric currently tracks 482 actively recruiting clinical trials with at least one location in Massachusetts. The total number of registered studies—including active but not currently enrolling trials—is 482. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Massachusetts?
Massachusetts hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Multiple Myeloma, Obesity, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Massachusetts serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Massachusetts?
To join a clinical trial in Massachusetts, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Massachusetts maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Massachusetts
NCT06667908 Phase 2
Recruiting
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolida...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
130 pts
Location
United States, Australia, Brazil
Sponsor
Johnson & Johnson Enterprise I
NCT07275021 N/A
Recruiting
Cerebral/ Cortical Visual Impairment: Screening, Identification and Outcome Pred...
Condition
Preterm Less Than 32wks With IVH, WMI/PVL
Enrollment
60 pts
Location
United States
Sponsor
Brigham and Women's Hospital
NCT04661358 Phase 3
Recruiting
Fenofibrate for Prevention of DR Worsening
Condition
Diabetic Retinopathy
Enrollment
560 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
NCT06249555 N/A
Recruiting
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With C...
Condition
Crohn's Disease
Enrollment
300 pts
Location
United States, Canada
Sponsor
Alimentiv Inc.
NCT07204340 Phase 1
Recruiting
TLN-372 in Advanced KRAS Mutant Solid Tumors
Condition
KRAS Mutant Solid Tumors
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
Treeline Biosciences, Inc.
NCT06300450 N/A
Recruiting
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Pat...
Condition
Peripheral Artery Disease
Enrollment
400 pts
Location
United States
Sponsor
Brigham and Women's Hospital
NCT01356290 Phase 2
Recruiting
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ...
Condition
Medulloblastoma Recurrent
Enrollment
232 pts
Location
United States, Austria, Czechia
Sponsor
Medical University of Vienna
NCT03032835 N/A
Recruiting
Partners Calciphylaxis Biobank
Condition
Calciphylaxis
Enrollment
300 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07536906 N/A
Recruiting
Falls Validation Study
Condition
Intracranial Bleed
Enrollment
4,000 pts
Location
United States, Canada
Sponsor
Dr. Kerstin de Wit
NCT06721455 N/A
Recruiting
Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery
Condition
Heart Surgery
Enrollment
50 pts
Location
United States
Sponsor
Boston Children's Hospital
NCT06400004 Phase 3
Recruiting
Lumason® Infusion vs. Bolus Administrations
Condition
Heart Diseases
Enrollment
106 pts
Location
United States
Sponsor
Bracco Diagnostics, Inc
NCT06253104 N/A
Recruiting
Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
Condition
Heart Failure
Enrollment
60 pts
Location
United States
Sponsor
Tufts Medical Center
NCT06770582 Phase 2
Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Ther...
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
160 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT05019625 N/A
Recruiting
Biomarker Development for Muscular Dystrophies
Condition
Myotonic Dystrophy
Enrollment
465 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT03217006 N/A
Recruiting
Randomization of Single vs Multiple Arterial Grafts
Condition
Coronary Artery Disease
Enrollment
4,300 pts
Location
United States, Austria, Brazil
Sponsor
Weill Medical College of Corne
NCT05665491 N/A
Recruiting
Role of Parent Interpretation Bias in the Transmission of Anxiety to Children
Condition
Anxiety
Enrollment
300 pts
Location
United States
Sponsor
Mclean Hospital
NCT06585618 N/A
Recruiting
A Multicenter Pediatric Deep Brain Stimulation Registry
Condition
Dystonia
Enrollment
100 pts
Location
United States
Sponsor
Boston Children's Hospital
NCT05241418 N/A
Recruiting
Atrial Late Gadolinium Enhancement in Patients with Repaired Congenital Heart Di...
Condition
Congenital Heart Disease
Enrollment
50 pts
Location
United States
Sponsor
Boston Children's Hospital
NCT04655404 EARLY_Phase 1
Recruiting
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK F...
Condition
High Grade Glioma
Enrollment
15 pts
Location
United States, Australia, Canada
Sponsor
Nationwide Children's Hospital
NCT05573126 Phase 1, Phase 2
Recruiting
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients...
Condition
Hormone Receptor-positive Breast Cancer
Enrollment
95 pts
Location
United States, Spain, United Kingdom
Sponsor
Ellipses Pharma
NCT03029325 N/A
Recruiting
Molecular and Genetic Analysis of Lung Cancer
Condition
Lung Cancer
Enrollment
15,000 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT07220460 Phase 2
Recruiting
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With D...
Condition
Bipolar I or II Disorder
Enrollment
200 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
NCT03291223 N/A
Recruiting
Gaucher Disease Outcome Survey (GOS)
Condition
Gaucher Disease
Enrollment
1,257 pts
Location
United States
Sponsor
Shire
NCT06967805 Phase 2
Recruiting
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis...
Condition
Idiopathic Pulmonary Fibrosis
Enrollment
164 pts
Location
United States, Argentina, Australia
Sponsor
Mediar Therapeutics
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology